Broadwood Partners, L.P.
10% Owner at Insight Molecular Diagnostics Inc. (IMDX)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return+22.4%
vs. S&P 500+18.8%
Beat the market100%
Paper profit on buys−$110K
Total bought / sold$2.0M / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Apr 27SEC | IMDXInsight Molecular Diagnostics Inc. | Buy | 280,38112,395,081 held (+2%) | $3.50 | $981K | -3.7% |
| Apr 27SEC | IMDXInsight Molecular Diagnostics Inc. | Buy | 012,395,081 held (+0%) | — | $0 | — |
| Apr 27SEC | IMDXInsight Molecular Diagnostics Inc. | Buy | 38,88012,433,961 held (+0%) | $3.53 | $137K | -4.5% |
| Apr 27SEC | IMDXInsight Molecular Diagnostics Inc. | Buy | 012,433,961 held (+0%) | — | $0 | — |
| Apr 27SEC | IMDXInsight Molecular Diagnostics Inc. | Buy | 250,92312,684,884 held (+2%) | $3.64 | $913K | -7.4% |
| Apr 27SEC | IMDXInsight Molecular Diagnostics Inc. | Buy | 012,684,884 held (+0%) | — | $0 | — |
- Buy
10% Owner Broadwood Partners, L.P. bought $981K of IMDX at $3.50 — first open-market purchase in our records.